Cargando…
Does n-3 LCPUFA supplementation during pregnancy increase the IQ of children at school age? Follow-up of a randomised controlled trial
INTRODUCTION: Despite recommendations that pregnant women increase their docosahexaenoic acid (DHA) intake to support fetal brain development, a recent systematic review found a lack of high-quality data to support the long-term effects of DHA supplementation on children's neurodevelopment. MET...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4874207/ https://www.ncbi.nlm.nih.gov/pubmed/27188814 http://dx.doi.org/10.1136/bmjopen-2016-011465 |
_version_ | 1782433019652472832 |
---|---|
author | Gould, Jacqueline F Treyvaud, Karli Yelland, Lisa N Anderson, Peter J Smithers, Lisa G Gibson, Robert A McPhee, Andrew J Makrides, Maria |
author_facet | Gould, Jacqueline F Treyvaud, Karli Yelland, Lisa N Anderson, Peter J Smithers, Lisa G Gibson, Robert A McPhee, Andrew J Makrides, Maria |
author_sort | Gould, Jacqueline F |
collection | PubMed |
description | INTRODUCTION: Despite recommendations that pregnant women increase their docosahexaenoic acid (DHA) intake to support fetal brain development, a recent systematic review found a lack of high-quality data to support the long-term effects of DHA supplementation on children's neurodevelopment. METHODS AND ANALYSIS: We will assess child neurodevelopment at 7 years of age in follow-up of a multicentre double-blind randomised controlled trial of DHA supplementation in pregnancy. In 2010–2012, n=2399 Australian women with a singleton pregnancy <21 weeks’ gestation were randomised to receive 3 capsules daily containing a total dose of 800 mg DHA/day or a vegetable oil placebo until birth. N=726 children from Adelaide (all n=97 born preterm, random sample of n=630 born at term) were selected for neurodevelopmental follow-up and n=638 (preterm n=85) are still enrolled at 7 years of age. At the 7-year follow-up, a psychologist will assess the primary outcome, IQ, with the Wechsler Abbreviated Scale of Intelligence, Second Edition. Specific measures of executive functioning (Fruit Stroop and the Rey Complex Figure), attention (Test of Everyday Attention for Children), memory and learning (Rey Auditory Verbal Learning Test), language (Clinical Evaluation of Language Fundamentals, Fourth Edition) and basic educational skills (Wide Range Achievement Test, Fourth Edition) will also be administered. Caregivers will be asked to complete questionnaires measuring behaviour and executive functioning. Families, clinicians and research personnel are blinded to group assignment with the exception of families who requested unblinding prior to the follow-up. All analyses will be conducted according to the intention-to-treat principal. ETHICS AND DISSEMINATION: All procedures will be approved by the relevant institutional ethics committees prior to start of the study. The results of this study will be disseminated in peer-reviewed journal publications and academic presentations. TRIAL REGISTRATION NUMBERS: ACTRN12605000569606 and ACTRN12614000770662. |
format | Online Article Text |
id | pubmed-4874207 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-48742072016-05-27 Does n-3 LCPUFA supplementation during pregnancy increase the IQ of children at school age? Follow-up of a randomised controlled trial Gould, Jacqueline F Treyvaud, Karli Yelland, Lisa N Anderson, Peter J Smithers, Lisa G Gibson, Robert A McPhee, Andrew J Makrides, Maria BMJ Open Obstetrics and Gynaecology INTRODUCTION: Despite recommendations that pregnant women increase their docosahexaenoic acid (DHA) intake to support fetal brain development, a recent systematic review found a lack of high-quality data to support the long-term effects of DHA supplementation on children's neurodevelopment. METHODS AND ANALYSIS: We will assess child neurodevelopment at 7 years of age in follow-up of a multicentre double-blind randomised controlled trial of DHA supplementation in pregnancy. In 2010–2012, n=2399 Australian women with a singleton pregnancy <21 weeks’ gestation were randomised to receive 3 capsules daily containing a total dose of 800 mg DHA/day or a vegetable oil placebo until birth. N=726 children from Adelaide (all n=97 born preterm, random sample of n=630 born at term) were selected for neurodevelopmental follow-up and n=638 (preterm n=85) are still enrolled at 7 years of age. At the 7-year follow-up, a psychologist will assess the primary outcome, IQ, with the Wechsler Abbreviated Scale of Intelligence, Second Edition. Specific measures of executive functioning (Fruit Stroop and the Rey Complex Figure), attention (Test of Everyday Attention for Children), memory and learning (Rey Auditory Verbal Learning Test), language (Clinical Evaluation of Language Fundamentals, Fourth Edition) and basic educational skills (Wide Range Achievement Test, Fourth Edition) will also be administered. Caregivers will be asked to complete questionnaires measuring behaviour and executive functioning. Families, clinicians and research personnel are blinded to group assignment with the exception of families who requested unblinding prior to the follow-up. All analyses will be conducted according to the intention-to-treat principal. ETHICS AND DISSEMINATION: All procedures will be approved by the relevant institutional ethics committees prior to start of the study. The results of this study will be disseminated in peer-reviewed journal publications and academic presentations. TRIAL REGISTRATION NUMBERS: ACTRN12605000569606 and ACTRN12614000770662. BMJ Publishing Group 2016-05-17 /pmc/articles/PMC4874207/ /pubmed/27188814 http://dx.doi.org/10.1136/bmjopen-2016-011465 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
spellingShingle | Obstetrics and Gynaecology Gould, Jacqueline F Treyvaud, Karli Yelland, Lisa N Anderson, Peter J Smithers, Lisa G Gibson, Robert A McPhee, Andrew J Makrides, Maria Does n-3 LCPUFA supplementation during pregnancy increase the IQ of children at school age? Follow-up of a randomised controlled trial |
title | Does n-3 LCPUFA supplementation during pregnancy increase the IQ of children at school age? Follow-up of a randomised controlled trial |
title_full | Does n-3 LCPUFA supplementation during pregnancy increase the IQ of children at school age? Follow-up of a randomised controlled trial |
title_fullStr | Does n-3 LCPUFA supplementation during pregnancy increase the IQ of children at school age? Follow-up of a randomised controlled trial |
title_full_unstemmed | Does n-3 LCPUFA supplementation during pregnancy increase the IQ of children at school age? Follow-up of a randomised controlled trial |
title_short | Does n-3 LCPUFA supplementation during pregnancy increase the IQ of children at school age? Follow-up of a randomised controlled trial |
title_sort | does n-3 lcpufa supplementation during pregnancy increase the iq of children at school age? follow-up of a randomised controlled trial |
topic | Obstetrics and Gynaecology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4874207/ https://www.ncbi.nlm.nih.gov/pubmed/27188814 http://dx.doi.org/10.1136/bmjopen-2016-011465 |
work_keys_str_mv | AT gouldjacquelinef doesn3lcpufasupplementationduringpregnancyincreasetheiqofchildrenatschoolagefollowupofarandomisedcontrolledtrial AT treyvaudkarli doesn3lcpufasupplementationduringpregnancyincreasetheiqofchildrenatschoolagefollowupofarandomisedcontrolledtrial AT yellandlisan doesn3lcpufasupplementationduringpregnancyincreasetheiqofchildrenatschoolagefollowupofarandomisedcontrolledtrial AT andersonpeterj doesn3lcpufasupplementationduringpregnancyincreasetheiqofchildrenatschoolagefollowupofarandomisedcontrolledtrial AT smitherslisag doesn3lcpufasupplementationduringpregnancyincreasetheiqofchildrenatschoolagefollowupofarandomisedcontrolledtrial AT gibsonroberta doesn3lcpufasupplementationduringpregnancyincreasetheiqofchildrenatschoolagefollowupofarandomisedcontrolledtrial AT mcpheeandrewj doesn3lcpufasupplementationduringpregnancyincreasetheiqofchildrenatschoolagefollowupofarandomisedcontrolledtrial AT makridesmaria doesn3lcpufasupplementationduringpregnancyincreasetheiqofchildrenatschoolagefollowupofarandomisedcontrolledtrial |